Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
Globe Newswire•02/11/2026•08:00 ET
0
Key Highlights
- ➤China Resources Medical Devices becomes exclusive distributor across 19 PRC markets
- ➤Baird Medical receives initial order worth approximately RMB 6 million ($900,000)
- ➤Agreement targets regions where Baird historically had limited direct commercial presence
- ➤Baird’s MWA system is FDA-cleared for soft tissue ablation
- ➤Baird Medical is expanding commercial infrastructure in the U.S. and internationally
Expert Statements
Haimei Wu, Chairwoman and CEO of Baird Medical
“This partnership with China Resources Medical Devices, one of the leading medical technology distributors in the PRC, provides another important validation of our technology. It will further strengthen our leadership position in China and help accelerate access to hospitals in previously untapped regions”
Haimei Wu, Chairwoman and CEO of Baird Medical
“With their extensive distribution network and nationwide prominence, we believe that adding our products to China Resources’ portfolio could help drive further adoption of our MWA technology throughout the country. We remain committed to growing our business in the Chinese market, and expect that this agreement will play an important role in achieving this goal while we continue to expand in other key global markets, including the U.S.”
China Resources Medical Devices to serve as exclusive distributor for Baird’s microwave ablation (MWA) products in 19 markets in the PRC
Agreement includes initial purchase order of RMB 6 million ($900,000)
Get started
Create a free account to read the full story.